The molecular subtyping of breast cancer and its clinical treatment significance / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 2309-2312, 2018.
Article
in Zh
| WPRIM
| ID: wpr-807835
Responsible library:
WPRO
ABSTRACT
The breast cancer is a usual and serious malignant tumor which threatens the women′s health.Molecular subtyping bases on the molecular level, and provides a new classification method for the breast cancer pathology classification, and plays an important guidance significance for the clinical treatment.At present, the breast cancer molecular subtyping is mainly divided into the following subtypes: the Luminal A type and Luminal B type, HER-2 overexpression and the triple negative breast cancer.Different molecular subtyping has different characteristics in treatment reaction, prognosis and the clinical application situation.
Full text:
1
Index:
WPRIM
Type of study:
Guideline
/
Prognostic_studies
Language:
Zh
Journal:
Chinese Journal of Primary Medicine and Pharmacy
Year:
2018
Type:
Article